Effect of Ivermectin 600 mcg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial
Results for the 600µg/kg arm of ACTIV-6. See
[Naggie].
Naggie et al., 15 Dec 2022, Double Blind Randomized Controlled Trial, placebo-controlled, USA, preprint, 29 authors, trial
NCT04885530 (history).
Contact:
susanna.naggie@duke.edu.
Abstract: medRxiv preprint doi: https://doi.org/10.1101/2022.12.15.22283488; this version posted December 15, 2022. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.
1
Effect of Ivermectin 600 µg/kg for 6 days vs Placebo on Time to Sustained Recovery in
Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial
Susanna Naggie, MD, MHS,1,2 David R. Boulware, MD, MPH,3 Christopher J. Lindsell, PhD,4
Thomas G. Stewart, PhD,5 Stephen C. Lim, MD,6 Jonathan Cohen, MD,7 David Kavtaradze,
MD,8 Arch P. Amon, MD,9 Ahab Gabriel, MD,10 Nina Gentile, MD,11 G. Michael Felker, MD,
MHS,1,2 Russell L. Rothman, MD, DPP,4 Dushyantha Jayaweera, MD,12 Matthew W. McCarthy,
MD,13 Mark Sulkowski, MD,14 Sybil Wilson, RN,1 Allison DeLong, BS,1 April Remaly, BA,1
Rhonda Wilder, MS,1 Sean Collins, MD, MSci,4,15 Sarah E. Dunsmore, PhD,16 Stacey J. Adam,
PhD,17 Florence Thicklin,18 George J. Hanna, MD,19 Adit A. Ginde, MD, MPH,20 Mario Castro,
MD, MPH,21 Kathleen McTigue, MD, MPH, MS,22 Elizabeth Shenkman, PhD,23 Adrian F.
Hernandez, MD, MHS1,2 for the Accelerating Covid-19 Therapeutic Interventions and Vaccines
(ACTIV)-6 Study Group and Investigators
1
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC;
2
Department of Medicine, Duke University School of Medicine, Durham, NC; 3Division of
Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, MN; 4
University Medical Center, Nashville, TN; 5School of Data Science, University of Virginia,
Charlottesville, VA; 6University Medical Center New Orleans, Louisiana State University Health
Sciences Center, New Orleans, LA; 7Jadestone Clinical Research, LLC, Silver Spring, MD;
8
David Kavtaradze, MD, Inc., Cordele, GA; 9Lakeland Regional Medical Center, Lakeland, FL;
10
Focus Clinical Research Solutions, Charlotte, NC; 11Department of Emergency Medicine,
Lewis Katz School of Medicine at Temple University, Philadelphia, PA; 12Department of
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
medRxiv preprint doi: https://doi.org/10.1101/2022.12.15.22283488; this version posted December 15, 2022. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.
2
Medicine, Miller School of Medicine, University of Miami, Miami, FL; 13Weill Cornell
Medicine, New York, NY; 14Division of Infectious Diseases, Johns Hopkins University,
Baltimore, MD; 15Veterans Affairs Tennessee Valley Healthcare System, Geriatric Research,
Education and Clinical Center (GRECC), Nashville, TN; 16National Center for Advancing
Translational Sciences, Bethesda, MD; 17Foundation for the National Institutes of Health,
Bethesda, MD; 18Stakeholder Advisory Committee, Pittsburgh, PA; 19Biomedical Advanced
Research and Development Authority, Washington, DC; 20University of Colorado School of
Medicine, Aurora, CO; 21Division of Pulmonary, Critical Care and Sleep Medicine, University of
Missouri-Kansas City School of Medicine, Kansas City, KS; 22Department of Medicine,
University of Pittsburgh Medical Center, Pittsburgh, PA; 23Department of Health Outcomes..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit